Caribou Biosciences CRBU
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.59 | 105.23 | -0.28 | -28,453 | -26 | |
| 2025Q3 | 2.33 | 106.72 | -0.30 | -29,400 | -28 | |
| 2025Q2 | 1.26 | 87.95 | -0.58 | -47,578 | -54 | |
| 2025Q1 | 0.91 | 107.31 | -0.43 | -42,913 | -40 | |
| 2024Q4 | 1.59 | 109.51 | -0.39 | -38,875 | -35 | |
| 2024Q3 | 1.96 | 110.25 | -0.38 | -38,238 | -35 | |
| 2024Q2 | 1.64 | 115.40 | -0.42 | -43,501 | -38 | |
| 2024Q1 | 5.14 | 111.56 | -0.46 | -46,002 | -41 | |
| 2023Q4 | 5.73 | 109.12 | -0.40 | -37,442 | -35 | |
| 2023Q3 | 4.78 | 146.30 | -0.04 | -14,633 | -10 | |
| 2023Q2 | 4.25 | 111.35 | -0.48 | -32,868 | -30 | |
| 2023Q1 | 5.31 | 110.95 | -0.46 | -31,116 | -28 | |
| 2022Q4 | 6.28 | 113.59 | -0.45 | -30,578 | -27 | |
| 2022Q3 | 10.55 | 99.59 | -0.44 | -26,537 | -27 | |
| 2022Q2 | 5.43 | 106.50 | -0.43 | -28,431 | -27 | |
| 2022Q1 | 9.18 | 109.25 | -0.32 | -20,853 | -19 | |
| 2021Q4 | 15.09 | 112.42 | 0.09 | -20,405 | -18 | |
| 2021Q3 | 23.87 | 83.16 | 0.58 | -17,436 | -21 | |
| 2021Q2 | 111.61 | -1.39 | -15,963 | -14 | ||
| 2021Q1 | 100.16 | -1.39 | -13,175 | -13 |